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Abstract Using RT-PCR-based cDNA cloning, we identified
novel splice variants of amphiphysin I, termed amph Ir, that are
expressed specifically in retina. In comparison with the prototype
amphiphysin I, amph Ir contained two novel insertions (inserts A
and B) and one deletion. Insert A is only 9 bp in length but
appears to be a determinant for the retina-specific expression. In
contrast, insert B is a large domain of 1740 bp and two shorter
transcripts with 3P-truncated insert B were also expressed. All the
insert sequences were present as unidentified exons in the
amphiphysin I gene on human chromosome 7. Western blot
analysis of various rat tissues with anti-insert B antibody
confirmed the presence and tissue specificity of the variant
proteins. . 2002 Published by Elsevier Science B.V. on behalf
of the Federation of European Biochemical Societies.
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1. Introduction
Amphiphysin I (amph I) is a nerve terminal-enriched pro-
tein which participates in synaptic vesicle endocytosis by bind-
ing to dynamin GTPase via its Src homology 3 (SH3) domain
and targeting dynamin to the neck of clathrin-coated pits.
Amph I also interacts with a variety of proteins other than
dynamin and may thus serve as an adapter molecule regulat-
ing the endocytic process [1,2]. Many proteins implicated in
synaptic vesicle tra⁄cking appear to be present in multiple
isoforms or splice variants [3]. Multiple splice variants of am-
phiphysin II (amph II), an isoform of amph I, have been
reported [4^6]. These variants may be important to di¡eren-
tiate their molecular partners [7]. Some of the variants show a
tissue-speci¢c expression, implying that they have distinct
roles in the vesicular recycling process unique to each cell
type.
Amph I is highly expressed in nervous tissues including
retina and some other tissues such as testis, lung, and adrenal
gland [8^11]. A variant of amph I lacking 42 amino acid
residues was found recently in a breast cancer tissue [9].
This is the only splice variant of amph I described so far. In
the present study, we identify novel amph I variants that are
transcribed speci¢cally in retina from the authentic amph I
gene on human chromosome 7.
2. Materials and methods
2.1. Tissue samples
Human retinal tissue was collected from patients under surgery and
frozen immediately. Experiments were undertaken with the under-
standing and written consent of each subject in accordance with the
Code of Ethics of the World Medical Association (Declaration of
Helsinki). Fresh rat tissues were obtained from killed animals (adult
Wistar rats) and quick-frozen in liquid nitrogen. All experiments with
animals, including rabbits for immunization, were carried out in ac-
cordance with the NIH Guidelines regarding the care and use of
animals for experimental procedures.
2.2. Reverse transcription polymerase chain reaction (RT-PCR) and
cDNA cloning
The PolyATtract0 System 1000 and Access RT-PCR System (both
from Promega) were used for mRNA puri¢cation and RT-PCR, re-
spectively. From 40 mg of tissue samples, mRNA was isolated accord-
ing to the manufacturer’s protocol. The reaction mixture for RT-PCR
(50 Wl) contained the reaction bu¡er, 5 U each of AMV reverse tran-
scriptase/T£ DNA polymerase, 0.2 mM dNTPs, 1 WM primers and
10 ng of mRNA isolated from various tissues. Resulting PCR prod-
ucts were separated by agarose gel electrophoresis, puri¢ed using
DEAE-cellulose paper, blunt-ended and ligated into the EcoRV site
of a zero-background cloning vector pZErO 2.1 (Invitrogen). After
transforming Escherichia coli TOP10FP competent cells, recombinant
plasmids were puri¢ed and sequenced on both strands with appropri-
ate primers and a premixed cycle sequencing reagent using ABI
Prism1 373 sequencer (Perkin-Elmer).
The following oligonucleotides were used as primers for RT-PCR
ampli¢cations. F1 (5P-ATGGCCGACATCAAGACGGG-3P), F2 (5P-
ATGTCTCAGACATTGCCCTGG-3P), F3 (5P-CAGGTGGAAAT-
GAACAACTG-3P), F4 (5P-GAGCGCCCAGAATGAGGT-3P), rF4
(5P-AGCTCCCAGAGCGAGGT-3P), F5 (5P-AACTGGGTGACC-
AGCACG-3P), rF6 (5P-GAGGAAACTCCTAACAGTGG-3P), R1
(5P-CCAGGGCAATGTCTGAGACAT-3P), R2 (5P-CTAATCTAA-
GCGTCGGGTGAAG-3P), rR2 (5P-CTATTCTAGGTGTCGTGT-
GAAG-3P), R3 (5P-CTCTATGACCACCGAAGGA-3P), R4 (5P-GG-
TGATGGTGTCTTTGCAAT-3P), rR5 (5P-ATGACCTTCCTTGAG-
CAGG-3P). Approximate locations of these primers are shown in
Figs. 1 and 3B. Primers based on rat sequences are designated by ‘r’.
2.3. Northern blot analysis
Total RNA extracted from various rat tissues using the acid gua-
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nidinium^phenol^chloroform method was electrophoresed in 1% aga-
rose/2.2 M formaldehyde gels and transferred with 0.05 M NaOH
onto Hybond-Nþ membrane (Amersham). The rat insert B1 region
was ampli¢ed by RT-PCR using rat retinal RNA and primer sets rF6/
rR5. The resulting product of 384 bp was puri¢ed, 32P-labeled, and
then used as a hybridization probe.
2.4. Western blot analysis
Frozen tissues were dissolved in sodium dodecyl sulfate^polyacryl-
amide gel electrophoresis (SDS^PAGE) sample bu¡er, boiled for
2 min, and subjected to 6% SDS^PAGE. Western blotting was per-
formed according to a standard procedure. Brie£y, separated proteins
in the gel were transferred electrophoretically to nitrocellulose mem-
branes. Blots were incubated successively with primary antibodies,
peroxidase-labeled anti-immunoglobulin secondary antibodies, and
then the peroxidase activity was visualized with 0.05% 4-methoxy-1-
naphthol and 0.015% hydrogen peroxide.
2.5. Preparation of antibody against insert B1
The human insert B1 (174 amino acids) was expressed in bacteria as
a glutathione S-transferase (GST) fusion protein. To prepare the ex-
pression construct, amph Ir cDNA (CT2) was ampli¢ed by PCR with
primers 5P-CCGGATCCCGACTGACTCTTCAGAAAGTC-3P and
5P-CCGAATTCCTTTTGACACGCCTCCACAC-3P that were de-
signed to amplify the entire region of insert B1 with terminal restric-
tion sites for in-frame insertion into the pGEX-3X vector (BamHI and
EcoRI sites are underlined). The recombinant plasmid was used to
transform E. coli strain JM109 and veri¢ed by DNA sequencing. The
GST insert B1 fusion protein was produced in the same host and
puri¢ed on glutathione-Sepharose 4B according to the manufacturer’s
instructions (Pharmacia).
The puri¢ed protein was emulsi¢ed with Freund’s complete adju-
vant and injected subcutaneously into two rabbits. Antibody titers
were monitored by immunoblotting on serum samples collected after
several booster injections. The pooled antiserum with high titer was
a⁄nity-puri¢ed by successive adsorptions to nitrocellulose membrane
strips blotted with GST or GST insert B1 fusion protein (antigen).
The GST membrane removed antibodies reactive to GST and insert
B1-speci¢c antibodies were eluted from the second membrane.
3. Results
3.1. Presence of multiple mRNA variants of amph I in retina
Since multiple bands migrating more slowly than amph I
had been detected on Western blots of retina tissue probed
with anti-amph I antibodies (shown in Fig. 5A), we suspected
that novel amph I variants with additional domains are ex-
pressed in retina. To see if this is the case, RNA isolated from
human retina was subjected to RT-PCR ampli¢cations with
two primer sets that target the 5P-half (F1/R1) or 3P-half (F2/
R2) of the canonical amph I mRNA (GenBank accession
number U07616, see Fig. 1A for primer positions). The
PCR products were cloned into a vector and sequenced.
Two out of eight 5P-half clones showed a sequence identical
to the authentic amph I cDNA (designated NT1 in Fig. 1B).
The other clones, however, contained a nine nucleotide inser-
tion after the second letter of the triplet encoding Pro249
(NT2). The insertion introduces an addition of three amino
acids but no frame shifting downstream (Fig. 3B). Similarly,
the 3P-half clones consisted of a canonical amph I (CT1) and a
novel variant clone CT2 that contained a 174 amino acid
insert (insert B1) after Pro394 and a 42 amino acid deletion
between Leu424 and Ile467 (Fig. 1B). The deleted segment
was identical to the one deleted in the ‘non-neuronal form’
of amph I we reported previously [9].
To further analyze mRNA variants harboring the insert B1,
a forward primer F3 was designed within the insert and RT-
PCR was performed using the primer F3 and a reverse primer
R3. In the resulting cDNA clones, additional inserts were
identi¢ed: insert B2 in CT3, inserts B2 and B3 in CT4, and
insert C in CT5 (Fig. 1B). Clones CT3 and CT4 had unin-
terrupted open reading frames, whereas CT5 would encode a
truncated protein due to a termination signal TGA within
insert C as the sixth codon following Leu424. All the clones
had the 42 amino acid deletion after Leu424.
Next, we assessed whether mRNA species containing both
inserts, A and B, are expressed in retina by RT-PCR with the
primer pair F4/R2, where the 3P nine nucleotide sequence of
F4 was identical to that of insert A. All the cDNA clones
obtained from this ampli¢cation contained the inserts A and
B1, and lacked the 42 amino acid region following Leu424
(NC1), suggesting that mRNA of this sequence organization
is the major amph I variant in retina. The results are consis-
tent with the view that in addition to the canonical amph I the
retina expresses a splice variant, termed amph Ir, with novel
inserts at two sites (after Pro249 and Pro 394) and a 42 amino
acid deletion after Leu424 (Fig. 1A). Amph Ir mRNA appears
to consist of three molecular species di¡ering from each other
Fig. 1. Amph I variants expressed in human retina. Numbers repre-
sent the amino acid residue number for canonical amph I (GenBank
accession U07616). Thick labeled bars designate the newly found in-
serts. Residue numbers for the insert are italicized. A: Schematic
representation of a retina-speci¢c amph I variant (amph Ir) as com-
pared to amph I. The coiled-coil and SH3 domains are shown by
shaded boxes. Approximate locations of PCR primers are indicated
by arrows. B: Summary of amph I variants identi¢ed in human reti-
na by RT-PCR-based cloning. Primer sets used for ampli¢cation are
shown on the left and clone names on the right. The blank bar in
CT5 denotes the untranslated region created by an in-frame stop co-
don within insert C.
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in the length of insert B. Although transcripts with B1+B2 (as
in CT3) and B1+B2+B3 (CT4) were detectable, these forms
are less abundant than the one with the B1 region only (CT2
and NC1).
3.2. Genomic organization of the amph I gene
Further evidence for the presence of amph Ir variants was
obtained from the analysis of genomic sequences. The human
amph I gene (AMPH) is located on chromosome 7p13^p14
[12]. BLAST search with the human amph I cDNA sequence
in the GenBank database extracted four overlapping BAC
clones assigned to chromosome 7 (AC011309, AC096581,
AC012490, and AC007245) that covered the entire region of
the amph I gene spanning about 250 kb (Fig. 2). Additional
searches for potential exons in this region using the FGE-
NESH algorithm revealed 26 putative exons. The splice donor
and acceptor sequences at the exon^intron boundaries were all
classical, including GT and AG dinucleotides on intron ends
(not shown). Out of 26 putative exons, 23 were present in the
amph I variant clones listed in Fig. 1. These cDNA sequences
matched exactly the genomic sequence except for a few nucle-
otide positions, and all the exon boundaries were precisely
spliced. The deleted segment in amph Ir (between amino acids
424 and 467) corresponds to exon 22. Exons 6 and 14 may be
a false prediction because they were not present in either
amph I or amph Ir. Exons 11 and 21 encoded insert A and
insert C, respectively. Insert B (B1+B2+B3) was encoded by a
single large exon (exon 18). Junctional sequences at B1/B2
(AG/GTAGA) and B2/B3 (AG/GTAAT) were very similar
to the splice donor consensus sequence AG/GTAAG. There-
fore, the shorter forms of amph Ir message are most likely to
be generated by splicing events occurring at these alternative
donor sites. The last exon (exon 26) contained the termination
codon TAG at nucleotides 109^111.
3.3. Tissue speci¢city of amph Ir mRNA expression in rat
Detection of insert A in transcripts was improved by de-
signing a PCR ampli¢cation that targets a short region span-
ning the insertion site. Ampli¢cation of human retina RNA
with the primer pair F5/R4 will bring about two RT-PCR
products of 91 bp and 100 bp, the latter being derived from
amph Ir. The result showed, however, that in addition to the
predicted products (b1 and b2) a slowly migrating fragment
(b3) was produced (Fig. 3A, lane 1). Strangely, cloning of the
total PCR product yielded plasmids with inserts of either b1
or b2, but not b3. When isolated b1 and b2 fragments were
simply mixed, denatured and annealed before electrophoresis,
fragment b3 was generated (lane 5), indicating that b3 is the
Fig. 2. Exon^intron organization of the human amph I gene deduced from the transcript analysis. The contiguous BAC clones are shown at
the top and predicted exons are shown underneath. The coding sequence for amph I appears on the minus strand of the BAC sequence. A hy-
pothetical mRNA composed of all the predicted exons is also shown at the bottom. Exons 11, 18, and 21 encode the amph Ir inserts A, B,
and C, respectively. Positions for translation initiation, termination, and polyadenylation signals are indicated. The shaded area in the ¢rst and
last exons stands for untranslated regions.
Fig. 3. RT-PCR analysis of insert A-containing mRNA in human
and rat tissues. A: DNA fragments ampli¢ed with a primer pair
F5/R4 £anking the insertion site on human retinal RNA were sepa-
rated by polyacrylamide gel electrophoresis (lane 1). Ampli¢cation
after cloning of the products (lanes 2 and 3). Lane 4, mixture of b1
and b2; lane 5, the mixture after denaturation^renaturation. Shown
on the right are probable duplex structures of the fragments. B:
Alignment of insert A sequences from human and rat retina. The
same primer set (F5/R4) successfully ampli¢ed the corresponding re-
gion (b2) in both species, although the F5 primer had three mis-
matches against the rat sequence. C: RT-PCR products from vari-
ous rat tissues. Fragment b2 of 100 bp is hardly visible here
because of the lower abundance of amph Ir in rat retina. Band b3
serves as a diagnostic marker for co-expression of amph I and
amph Ir in a particular tissue. M, 100 bp size marker; lanes 1, reti-
na; 2, testis; 3, adrenal gland; 4, cerebral cortex; 5, cerebellum; 6,
pons; 7, medulla oblongata; 8, skeletal muscle; 9, heart; 10, lung;
11, liver; 12, spleen; 13, kidney.
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heteroduplex formed between b1 and b2 fragments. The aber-
rant mobility of b3 in polyacrylamide gels is consistent with a
bent structure with a single-stranded loop. The same result
was obtained when rat retina RNA was ampli¢ed with prim-
ers F5/R4 (not shown). Sequences for b1 and b2 obtained
from both species were determined and the insert A sequence
is aligned in Fig. 3B. Thus, it is now clear that the amph I
variant containing 9 bp insert A, although with some sequence
variations, is also expressed in rat retina together with the
prototype amph I. A series of rat tissues were then examined
by RT-PCR to see whether amph Ir with insert A is expressed
in other tissues (Fig. 3C). The shorter band representing amph
I (b1) was detectable in nervous tissues including retina, as
well as testis and lung. The heteroduplex band b3, however,
was evident only in retina, suggesting retina-speci¢c expres-
sion of insert A.
The rat counterpart of amph Ir containing both inserts A
and B was next cloned from RT-PCR products ampli¢ed with
a primer pair rF4/rR2 using rat retina mRNA as a template.
Sequencing of the resulting clones revealed that a novel insert
of 471 bp was placed at the expected site after nucleotide 1182
of rat amph I cDNA (Y13381). The insert shares 76% homol-
ogy with the human insert B1, suggesting that this variant is
the rat counterpart of human NC1. Since no sequences ho-
mologous to the human inserts B2 and B3 were found in these
clones, the variant with inserts A and B1 appears to be the
most abundant form also in rat retina. Tissue speci¢city of the
insert B1 expression was then investigated by RT-PCR with
RNA from various rat tissues using a primer pair rF6/rR5
which ampli¢es a 384 bp segment within the insert (Fig.
4A). In contrast to insert A, insert B1 was expressed not
only in retina but also in other central nervous tissues, testis,
kidney and lung. To determine the size of transcripts contain-
ing insert B1, Northern blot analysis was performed (Fig. 4B).
In retina, a prominent band and a minor band were detected
at approximately 4 kb and 6 kb, respectively. The 6 kb tran-
script was not present in any other tissues, whereas the 4 kb
transcript appeared to be expressed also in central nervous
tissues at a lower level. These results are consistent with the
idea that the 4 kb and 6 kb transcripts encode the retina-
speci¢c amph Ir with inserts B1 and B1-B2-B3, respectively.
The weaker signal at 4 kb in other nervous tissues can be
accounted for by the variant with insert C (like CT5 in Fig.
1), which is indistinguishable in size from the B1-containing
amph Ir. The notion was corroborated by the Western blot
analysis shown below.
3.4. Analysis of retina-speci¢c amphiphysin I variants by
Western blotting
To determine the tissue distribution of amph I-related pro-
teins, rat tissue samples were subjected to Western blotting
using antibodies against human amph I or insert B1 protein
expressed in bacteria (Fig. 5). The anti-amph I antibody de-
tected the canonical amph I migrating at 128 kDa in the brain
and retina, as well as testis and lung. The antibody also rec-
ognized several bands with less mobility around 160^210 kDa,
designated ‘large forms’, that were present only in retina.
Similar bands were discernible also in human retina. Since
the epitope of this antibody resides in the C-terminal region
[9], the large forms appear to share the C-terminal domain of
amph I. As expected, immunoblotting with anti-insert B1 anti-
body failed to detect the canonical amph I in all the tissues,
but the large forms in retina were recognized by the antibody.
These results indicated that the large forms most likely repre-
sent the retina-speci¢c amph I variants containing insert B1
and B1 plus B2/B3. Apparent molecular size estimated from
the blot showed that the V160 kDa and V210 kDa bands
roughly correspond to amph Ir with insert B1 and B1-B2-B3,
respectively. Another interesting observation is that insert B1
antibody, but not amph I antibody, recognizes a protein mi-
grating at around 110 kDa in retina and in other tissues where
amph I is expressed (asterisk in Fig. 5). When the data for
cDNA cloning and transcript analysis are taken together, it is
strongly suggested that the 110 kDa protein is encoded by the
4 kb transcript shown in Fig. 4. In summary, we conclude that
amph I variants with novel insertions are expressed speci¢-
cally in retina, and that a truncated protein lacking the SH3
domain is co-expressed with amph I in various tissues.
4. Discussion
All the insertion sequences newly found in retinal cDNAs
were represented as hitherto unidenti¢ed exons in the genomic
sequence of the human amph I gene. Analysis of exon bound-
Fig. 4. Analysis of insert B-containing mRNA in rat tissues. A: Total RNA samples from rat tissues indicated at the top were subjected to
RT-PCR using rat insert B1-speci¢c primers (rF6/rR5). B: The same RNA samples were subjected to Northern blot analysis using the 32P-la-
beled probe prepared from the rF6/rR5 ampli¢cation product. Marker positions are labeled on the left.
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aries revealed that in 21 out of 25 junctional sites the point of
intron insertion occurs at the codon boundary. The frequency
(21/25= 84%) is signi¢cantly higher than the statistical expect-
ation for mammalian genes (44.3%) [13]. We made a similar
observation previously in amph II transcripts [5]. There is a
general preference for intron insertion at a codon boundary,
as opposed to the middle of a codon, that has been ascribed
to a consequence of gene evolution through the exon shu¥ing
mechanism [14].
In correlation to the domain structure of amph I protein [1],
the three insertion sites for inserts A, B, and C are situated
right next to the proline-rich, clathrin binding, and hydropho-
bic domains, respectively. The exon^intron organization of
the amph II gene is similar to that of the amph I gene
although the gene size of amph II is much smaller [6]. Anal-
ysis of homologous exons between the two genes indicated
that exon 11 of the amph I gene, the coding exon for insert
A, corresponds to exon 10 of amph II. Interestingly, as insert
A is speci¢c to amph I variants expressed in retina, the cor-
responding exon encodes an NLS-like segment speci¢c to the
amph II variant expressed in skeletal muscle (alternatively
called BIN1). Therefore, this small exon may be a signature
exon for tissue-speci¢c expression of amphiphysin variants.
The internal coding exon 18, which encodes insert B, is un-
usually large and extremely rare in the mammalian genome
[15]. Like the other domains in the amph I protein, this do-
main may well provide a site for interaction with unidenti¢ed
protein partner(s). However, attempts to predict interacting
proteins were unsuccessful because the deduced amino acid
sequence of insert B showed little homology to known pro-
teins.
The presence of a transcript containing insert C, which is
encoded by exon 21, was an unexpected ¢nding since it directs
a truncated translation product due to an in-frame termina-
tion signal in the insert. A protein of predicted size (V110
kDa) was indeed detected by anti-insert B1 antibody (Fig. 5).
The similar tissue distribution pattern of the 110 kDa protein
and amph I may suggest that they form a heterodimer in these
tissues. The cellular function of this protein should be di¡er-
ent from that of amph I as it lacks the C-terminal region
including the SH3 domain which is essential for the recruit-
ment of dynamin to the site of endocytosis. To our knowl-
edge, this is the ¢rst example of SH3-less amphiphysin-related
protein in higher eukaryotes. In this context, the protein may
be a functional homologue of the yeast amph I-like protein
Rvs161 lacking the SH3 domain that was suggested to be
involved in the control of the actin cytoskeleton [16].
The mammalian retina has a characteristic multi-layered
structure composed of known cellular constituents. Localiza-
tion of amph Ir protein in retina would provide a signi¢cant
clue to its physiological function. To this end, we have immu-
nostained rat retina with the anti-insert B1 antibody. As ex-
pected, the antibody stained the two synaptic layers termed
outer and inner plexiform layer (data not shown). Amph I
shows a similar distribution as stained with conventional anti-
bodies [10,17]. In addition to conventional synapses, retina
contains a morphologically distinctive synapse called ribbon
synapses. The ribbon synapse is considered to be specialized
for the continuous exocytotic release of neurotransmitters in
certain sensory neurons including photoreceptors and bipolar
cells of retina [18]. It is reasonable then to assume that ribbon
synapses also possess a unique vesicle-recycling machinery
and amph Ir may be involved as its essential component.
Attempts to determine the precise location of amph Ir in
retinal synapses are in progress.
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